SciSight Ecosystem
WoS SCIE Q3Scopus Q1SCImago #4,413CAS 3区Hybrid

Jaids-Journal of Acquired Immune Deficiency Syndromes

Abbreviation (ISO):JAIDS-J ACQ IMM DEF
Country: United States•WoS SCIE Quartile: Q3•Scopus SJR: 1.066•SCImago Rank: #4,413•Identifier (ISSN):1525-4135(Print)/1944-7884(Online)•Articles / Year: 269•Estimated Publication Fee (APC): $3,451 USD
Clarivate IF (2026)Q3
2.3
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
142

142 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate3.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
269articles/year
24.18% Gold OA•98.5% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.3)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.3)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.2)
🔵 Computed
20241.50đ
WoS Q3(IF: 2.9)
🔵 Computed
20231.50đ
WoS Q3(IF: 3.6)
🔵 Computed
20221.50đ
WoS Q3(IF: 3.771)
🔵 Computed
20211.50đ
WoS Q3(IF: 3.731)
🔵 Computed
20201.50đ
WoS Q3(IF: 3.475)
🔵 Computed
20191.50đ
WoS Q3(IF: 3.863)
🔵 Computed
20181.50đ
WoS Q3(IF: 4.116)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.

Topics Covered (Recognized by AI)
Medicine96.6%Biology90.1%Immunology80.7%Virology78.3%Family medicine73.7%Human immunodeficiency virus (HIV)71.6%Genetics63%Internal medicine62.5%Pathology49.1%Virus44.4%Mathematics33.6%Viral load32.9%Chemistry31%Statistics30%Sociology29.4%Biochemistry28.4%Psychology26.9%Demography26.3%Antiretroviral therapy25.7%Environmental health22.8%Surgery22.1%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,413Scopus Q1SCImago Profile
Scopus Coverage:1988-1994, 1996-1997, 1999-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.066

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
180

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.04

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,451 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,612
3-Year Documents702
Citable Documents661

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate55.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ1
Pharmacology (medical)Q1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Monthly
Founding Year
1999
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
IMMUNOLOGY
JCRSCIE
135/183Q3
INFECTIOUS DISEASES
JCRSCIE
87/141Q3
IMMUNOLOGY
JCISCIE
105/183Q3
INFECTIOUS DISEASES
JCISCIE
76/141Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—15315
20252.2229356
20242.92401,184
20233.62081,210
20223.7712512,630
20213.7312814,078
20203.4753707,728
20193.8634027,247
20184.1164218,336
2017—48611,034
2016—50214,224
2015—43814,626
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Jaids-Journal of Acquired Immune Deficiency Syndromes

WoS Q3
1245201820192020202120222023202420252.20
Annual Impact Factor Metric
2025:2.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d84a3833-d399-43db-8ea8-1f4cb23a2712
Database Updated: 2026-10-01